PubMed HealthSearch

Biomedical subjects

D J Mazzo

Publications and source records attributed to D J Mazzo.

7 recordsLinked to original sources

Analytical method comparison based upon statistical power calculations.

Testing for the equivalence of results generated by different analytical methodology is a common practice in the pharmaceutical sciences. Methodology changes are implemented for both scientific and economic reasons during a scientific study. Thus, the need to demonstrate the appropriateness of considering data generated by distinct methods as part of a single information population arises. This paper describes a rapid and simple approach to the statistical design and interpretation of method comparison experiments. The approach presented is based upon a statistical power calculation technique, a knowledge of the variability associated with the methods to be compared and the criteria for equivalence (the limits within which differences become immeasurable or, for practical purposes, insignificant). Reference tables are included which show necessary sample sizes for comparison experiments for common combinations of these three variables.

Chemistry Techniques, Analytical

Chemical equivalence of two polyetherpolyurethane foams as a vehicle for povidone-iodine solution: kinetic model for the loss of available iodine.

The loss of available iodine from povidone-iodine solution stored in contact with two different polyetherpolyurethane foams was monitored as a function of time and temperature. Statistical evaluation of the results for the four temperatures studied [ambient (25 degrees), 30, 45 and 55 degrees C] indicated the chemical equivalence of the two foams as storage and delivery systems for povidone-iodine solution in terms of solution stability. In addition, application of a first-order kinetic model to the data produced an acceptable fit. An Arrhenius-type evaluation of the resulting rate constants yielded a linear relationship which was shown to be useful for predicting loss of available iodine under ambient temperature conditions of storage.

Drug Stability

High-performance liquid chromatography of timolol and potential degradates on dynamically modified silica.

A novel method for the determination of timolol in pharmaceutical products has been developed and is described. The method employs high-performance liquid chromatography (HPLC) on silica dynamically modified with the cetyltrimethylamomonium cation to quantitate the analyte. The use of this type of reversed-phase HPLC system for timolol determinations results in improved quality of chromatography, especially in terms of peak tailing and peak efficiency, in comparison to chromatography on bonded-phase silica. Column-to-column as well as manufacturer-to-manufacturer reproducibility for this separation on silica columns has been obtained and is better in our hands than that encountered with bonded-phase column packings. The method has been shown to be linear for the compounds studied, comparably accurate and precise to bonded-phase methods and specific for timolol in a variety of pharmaceutical formulations. Under the conditions specified, timolol can be successfully separated from its three potential degradates. Possible explanations of the primary retention mechanisms for the analytes are offered.

Administration, Cutaneous

High-performance liquid chromatography with ultraviolet or electrochemical detection for the determination of dopazinol in a pharmaceutical formulation.

The high-performance liquid chromatographic (HPLC) analysis of dopazinol, an anti-Parkinsonian drug, using either ultraviolet (UV) absorbance detection at 282 nm or oxidative amperometric electrochemical detection at the glassy carbon electrode (+0.92 V vs. Ag/AgCl) is described and evaluated. The influence of such factors as mobile phase composition, pH and column temperature on the detection of dopazinol using both detectors is reported. The HPLC analysis of samples resulting from the development and evaluation of a pharmaceutical formulation demonstrated a precision of less than 2.5% (R.S.D.) in the working ranges of the UV and electrochemical detectors. The limits of detection were 100 ng/ml for the UV detector and 1 ng/ml for the electrochemical detector. The higher sensitivity of the latter makes its use appropriate for the analysis of samples with low concentrations of dopazinol. Studies to compare the UV and electrochemical detectors for the routine analysis of dopazinol in pharmaceutical formulations are presented.

Antiparkinson Agents

Reversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase.

An analytical method was developed for the determination of famotidine, potential degradates, and preservatives in several pharmaceutical formulations. The method employs reversed-phase chromatography on a silica column with a methanol-phosphate solution as the mobile phase. The influence of the concentration of phosphate and organic modifier are discussed. Accuracy and precision for this method along with assay data from different formulations of famotidine are presented. Two different commercial silica columns were tested with this method. Chromatographic differences related to the surface area and pore size of the silica are discussed.

Chemistry, Pharmaceutical